IL-2 ACTIVATED KILLER CELLS DISTINCT FROM NK AND T CELLS the top with a Pasteur pipette , and washed in CM

The lymphokine-activated killer cell (LAK) 1 system has been reported by us to represent a cytotoxic phenomenon distinct from either the classic cytotoxic thymusderived lymphocyte (CTL) or natural killer (NK) cell system on the basis of development kinetics, stimulus requirement, cytotoxic specificity, precursor location, and serologic phenotype of the LAK effector cells (1). The LAK system is unique in its simplicity of activation, since culture of nonadherent peripheral blood lymphocytes (PBL) for a minimum of 3 d in lectin-free lymphokine preparations rich in interleukin2 (IL-2) is the only requirement. As described earlier (1), the LAK phenomenon involves an activation mechanism that may be common to the many reports of nonclassic culture-induced lymphocyte-mediated cytotoxicities such as the mixed lymphocyte/leukocyte culture induced anomalous killers (2-6), NK-like killers (7, 8), fetal calf serum-induced killers (9-11), and lectin-induced killer cells (12). Therefore, this system is a most likely candidate for unifying the growing body of literature concerning these cytotoxicities, and for approaching the study of their biological significance. LAK can be generated from PBL of >90% of the cancer patients tested. One potential significance of the LAK cells is that they can efficiently lyse fresh single-cell suspensions of autologous fresh tumor cells, in addition to allogeneic fresh tumors and all cultured tumors tested, including those that are NK-resistant (1, 13), all of which LAK lyse optimally in a 4-h chromium-release assay. Since as yet no reproducible or consistent method is available for generation of human antitumor CTL, the potential for LAK as an important antitumor defense mechanism has encouraged further definition of the system. We have shown previously that the precursor of the LAK cell is nonadherent to plastic or nylon wool, and that its activation can be prevented by 2,000 rad of gamma irradiation. Therefore we studied in parallel the phenotype of the effectors and precursors of LAK cells, NK cells, and CTL and confirmed the distinct functional nature of each system by simultaneous activation cultures and

[1]  F. Greco,et al.  Human natural cell-mediated cytotoxicity , 1981, Cancer Immunology, Immunotherapy.

[2]  E. Reinherz,et al.  Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex , 1982, Cell.

[3]  A. Silva,et al.  Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression. , 1982, Journal of immunology.

[4]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor. , 1982, Cellular immunology.

[5]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[6]  J. Ortaldo,et al.  Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity. , 1982, Journal of immunology.

[7]  J. Roder,et al.  Studies of human natural killer cells. II. Analysis at the single cell level. , 1982, Journal of immunology.

[8]  S. Rosenberg,et al.  Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins. , 1982, Cancer research.

[9]  S. Rosenberg,et al.  5 – Production and Properties of Human IL-2 , 1982 .

[10]  W. Biddison,et al.  Phenotypes of human natural killer cell populations detected with monoclonal antibodies. , 1981, Journal of immunology.

[11]  E. Engleman,et al.  Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. , 1981, Journal of immunology.

[12]  S. Rosenberg,et al.  Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. , 1981, Cancer research.

[13]  C. Balch,et al.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.

[14]  S. Rosenberg,et al.  Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. , 1981, Journal of immunology.

[15]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity. , 1981, Journal of immunology.

[16]  H. Schellekens,et al.  Induction of Natural Killer Cell Activity and Allocytotoxicity in Human Peripheral Blood Lymphocytes after Mixed Lymphocyte Culture , 1981, Scandinavian journal of immunology.

[17]  R. Warnke,et al.  Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Omary,et al.  Human homologue of murine T200 glycoprotein , 1980, The Journal of experimental medicine.

[19]  E. Saksela,et al.  Isolation of human NK cells by density gradient centrifugation. , 1980, Journal of immunological methods.

[20]  S. Rosenberg,et al.  In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. , 1980, Journal of immunology.

[21]  S. Argov,et al.  Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures. , 1980, Journal of immunology.

[22]  E. Reinherz,et al.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. , 1980, Journal of immunology.

[23]  E. Reinherz,et al.  Monoclonal antibodies defining distinctive human T cell surface antigens. , 1979, Science.

[24]  M. Golightly,et al.  “NK‐like” cytotoxicity of human lymphocytes cultured in media containing fetal bovine serum , 1979, International journal of cancer.

[25]  C. Riccardi,et al.  Natural Killer Cells: Characteristics and Regulation of Activity , 1979, Immunological reviews.

[26]  E. Klein,et al.  Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells. , 1978, Journal of immunology.

[27]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. I. Growth of cells sensitized in vitro to alloantigens. , 1978, Journal of immunology.

[28]  F. Bach,et al.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells , 1978, Nature.

[29]  S. Golub,et al.  Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities. , 1978, Journal of immunology.

[30]  J. Ortaldo,et al.  Cytotoxic reactivity of human lymphocytes cultured in vitro. , 1977, Journal of immunology.

[31]  R. Herberman,et al.  Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor. , 1977, Journal of immunology.

[32]  S. Golub,et al.  Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes. , 1976, Cancer research.

[33]  F. Bach,et al.  Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors , 1976, The Journal of experimental medicine.